XML 72 R60.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Deficiency - Schedule of Common Share Option Activity (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
ACI Canada Legacy Performance Options [Member]    
Schedule of Common Share Option Activity [Line Items]    
Number of Options, Balance 265,642 265,642
Weighted Average Exercise Price, Balance ending $ 0.22 $ 0.22
Weighted Average Remaining Contractual Life (Years), Balance ending 3 years 2 months 23 days 3 years 5 months 23 days
Aggregate Intrinsic Value, Balance [1] $ 1,285,838 $ 1,506,321
Number of Options, Options exercisable 258,362  
Weighted Average Exercise Price, Options exercisable $ 0.22  
Weighted Average Remaining Contractual Life (Years), Options exercisable, 3 years 2 months 15 days  
Aggregate Intrinsic Value, Options exercisable [1] $ 1,250,821  
Stock Option [Member]    
Schedule of Common Share Option Activity [Line Items]    
Number of Options, Balance 2,054,121 888,529
Weighted Average Exercise Price, Balance ending $ 5.32 $ 4.58
Weighted Average Remaining Contractual Life (Years), Balance ending 8 years 9 months 18 days 8 years 4 months 9 days
Aggregate Intrinsic Value, Balance [2] $ 725,617 $ 1,159,843
Number of Options, Options exercisable 746,240  
Weighted Average Exercise Price, Options exercisable $ 4.5  
Weighted Average Remaining Contractual Life (Years), Options exercisable, 7 years 2 months 12 days  
Aggregate Intrinsic Value, Options exercisable [2] $ 563,504  
Number of Options, Granted 1,165,522  
Weighted Average Exercise Price, Granted $ 5.93  
Weighted Average Remaining Contractual Life (Years), Granted  
[1] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share. The calculation excludes options with an exercise price higher than the closing price of the Company’s shares on the reporting date
[2] The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common share. The calculation excludes options with an exercise price higher than the closing price of the Company’s share on the reporting date.